Pages that link to "Q28253305"

The following pages link to Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients (Q28253305):

Displaying 14 items.

• The involvement of Reelin in neurodevelopmental disorders (Q24632484) (← links)
• Reelin-Related Disturbances in Depression: Implications for Translational Studies (Q26768609) (← links)
• Schizophrenia: One Coat of Many Colors (Q27500448) (← links)
• Vldlr overexpression causes hyperactivity in rats. (Q30530996) (← links)
• Gene Expression Profiling in Rodent Models for Schizophrenia (Q34829319) (← links)
• Genome-wide association study of a quantitative disordered gambling trait (Q36315528) (← links)
• Epigenetic biomarkers in psychiatric disorders (Q37002342) (← links)
• The first decade and beyond of transcriptional profiling in schizophrenia. (Q37852180) (← links)
• Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins (Q39658665) (← links)
• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease (Q40299879) (← links)
• Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis (Q41073238) (← links)
• Gene expression biomarkers of response to citalopram treatment in major depressive disorder (Q41910462) (← links)
• Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood (Q42918709) (← links)
• Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population (Q49621363) (← links)